Telehealth GLP-1 Programs: What a Physician-Guided Plan Includes

A telehealth GLP-1 program provides medical weight-management services remotely through a secure online platform. Depending on the program and what is medically appropriate, treatment options may include medications containing semaglutide, tirzepatide, or another prescription weight-management medication.

In practical terms, medically guided treatment means a qualified, licensed healthcare provider evaluates whether prescription treatment is appropriate and oversees the patient's care. Depending on state law and the platform, care may be provided by a licensed physician or another qualified licensed prescriber, such as a nurse practitioner or physician assistant.

The provider may review:

• Height, weight, and BMI
• Medical and surgical history
• Current medications and allergies
• Previous weight-loss treatments
• Weight-related medical conditions
• Treatment goals and potential contraindications

This information helps the provider determine whether a GLP-1-based treatment may be appropriate for that individual.

Most telehealth programs begin with an online medical questionnaire. Patients may be asked about current weight and height, weight history, health conditions, prescriptions, previous surgeries, allergies, pregnancy status when relevant, previous GLP-1 use, and current symptoms.

Patients should answer accurately. Information that may seem unrelated to weight loss can still influence whether a medication is appropriate.

Submitting a questionnaire is not the same as automatically receiving a prescription. A licensed healthcare provider should review the patient's information and decide whether treatment is medically appropriate.

• Approve treatment when appropriate
• Request additional information
• Recommend a different treatment
• Request laboratory testing or further evaluation when appropriate
• Determine that prescription treatment is not appropriate

A legitimate prescription program should not guarantee medication before a clinical evaluation occurs.

Not always.

Depending on the patient's circumstances and applicable state requirements, an evaluation may involve a secure medical questionnaire, messaging, a phone consultation, or a video visit. An asynchronous evaluation may be appropriate in some situations, while others require additional communication or a synchronous visit.

The important part is that an actual licensed healthcare provider evaluates the patient rather than a prescription being generated automatically from a checkout form.

If treatment is appropriate, the provider can determine which available option may best fit the patient. Semaglutide and tirzepatide are commonly discussed, but they are not identical medications.

Both can reduce appetite and food intake. The most appropriate option is not necessarily the same for every patient.

GLP-1 medications are generally started at lower doses and increased gradually according to the treatment plan. This process is called titration.

Starting low and escalating gradually can help the body adjust. Gastrointestinal effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort can be harder to tolerate when treatment is increased too quickly.

Why dosing guidance matters

Dosing instructions are especially important when medication is dispensed in a multidose vial. A prescribed dose in milligrams and the units marked on a syringe are not interchangeable measurements. The number of syringe units depends on the medication's concentration.

After a prescription is issued, medication is dispensed by a pharmacy authorized to fill it. Depending on the prescription, a patient may receive a commercially manufactured medication or a compounded medication when legally permitted and medically appropriate.

Patients should know what they are receiving. The label should identify the drug, strength or concentration when applicable, patient directions, dispensing pharmacy, and storage instructions.

Compounded medications are different from FDA-approved commercial products such as Wegovy or Zepbound. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, or quality before they reach patients.

Qualified compounding pharmacies may prepare medications under specific federal and state requirements when legally permitted and medically appropriate. A compounded medication should not be described as generic, bioequivalent to, or interchangeable with an FDA-approved product.

Patients should be told:

• What medication they are receiving
• Its strength or concentration
• Exactly how much to administer
• Which registered pharmacy dispensed it
• How it should be stored
• How to reach the prescribing team or pharmacy with questions

Many telehealth programs arrange for the dispensing pharmacy to ship medication directly to the patient's home. Depending on the treatment, the package may include medication, administration supplies, alcohol pads, dosing directions, and storage information.

Review the shipment when it arrives and follow the pharmacy's storage instructions. Ask about damaged packaging, temperature exposure, missing supplies, or unexpected medication appearance before use.

The first shipment should not be the end of medical care. During treatment, the care team may monitor weight changes, appetite, side effects, medication tolerance, dose progression, adherence, nutrition, changes in health, and new medications.

What should follow-up look like?

Follow-up may happen through secure messaging, online check-ins, phone calls, video visits, or questionnaires. What matters is that patients have a clear way to reach the clinical team when questions or problems arise.

Common side effects of GLP-1-based medications are gastrointestinal and can include nausea, constipation, diarrhea, vomiting, abdominal discomfort, indigestion, and reduced appetite. Symptoms may be more noticeable when treatment begins or the dose increases.

A healthcare provider can help determine whether symptoms may be managed conservatively, whether dose escalation should be reconsidered, or whether further evaluation is needed. The goal is not to make someone so nauseated that they cannot eat; treatment should remain tolerable while supporting appropriate nutrition and hydration.

Medication can reduce appetite considerably, making adequate nutrition more important—not less. Patients still need protein, fluids, fiber, vitamins, minerals, essential fats, and other nutrients.

Significant weight loss can include some lean tissue. Adequate protein, resistance training, regular activity, and avoiding unnecessarily severe calorie restriction can help support muscle and physical function.

Weight loss is rarely linear. Faster initial loss may be followed by a slower period, weeks with little change, and eventually a plateau. That does not automatically mean the medication stopped working.

As body weight decreases, energy requirements generally decrease too. A good telehealth program should help patients understand these changes rather than treating every plateau as an automatic reason to increase the dose.

Should every patient reach the highest dose?

No. Higher is not automatically better.

• Treatment response and appetite
• Side effects and tolerability
• Current dose and time at that dose
• Treatment goals
• The prescribing provider's guidance

Some patients may progress according to the medication's schedule; others may need a different approach. Patients should not change their medication independently.

These details matter just as much as the advertised monthly price.

Patients should be cautious when a program:

• Guarantees a prescription before medical review
• Does not clearly involve a licensed healthcare provider
• Will not identify what medication is being prescribed
• Provides unclear dosing instructions
• Makes unrealistic weight-loss guarantees
• Has no clear way to contact the care team
• Makes pricing or recurring billing difficult to understand

Convenience should not require sacrificing transparency.

Telehealth itself does not determine whether treatment is appropriate or safe. What matters is the quality of care behind the platform.

• Appropriate patient screening
• Qualified licensed healthcare providers
• Legitimate prescription processing
• Appropriate pharmacy dispensing
• Clear dosing and side-effect education
• Ongoing access to clinical support

Patients also play an important role by providing accurate medical information and communicating health changes throughout treatment.

A telehealth GLP-1 program should be more than “order medication and wait for a package.” A medically guided program should follow a clear care pathway.

The convenience of telehealth can make weight-management care easier to access, but clinical oversight remains important. Patients should know what they are receiving, understand how to use it, know where it was dispensed, and have a clear way to contact their care team.

At Luma, eligible patients can complete an online medical evaluation reviewed by a licensed healthcare provider. When treatment is medically appropriate and prescribed, patients receive dosing guidance and ongoing support throughout their weight-management journey.